Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.

Also called NCT07717931

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 146 participants (enrolled count) (from the registry)
Sponsor
CMH Multan Institute of Medical Sciences (from the registry)
Registry
  • NCT NCT07717931
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07717931. Randomized; double masking; primary purpose prevention. Start 2025-08-01 (actual); primary completion 2026-01-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
Condition
Preeclampsia
Intervention (Drug)
Vitamin D (Cholecalciferol )
Intervention (Drug)
Placebo
Lead sponsor
CMH Multan Institute of Medical Sciences (class: other government)

Record details

Record id
cardio:ct-nct07717931
Content hash
c4acff9d3545a97c17f9d6e0de6499ec32fffa810bc5cbca11f817c0fe3ad680